Postmarketing Safety Concerns With Esketamine: A Disproportionality Analysis of Spontaneous Reports Submitted to the FDA Adverse Event Reporting System
May 25, 2021 DOI: 10.64239/pi-qt2702
Summary
AI-generated from the abstractEsketamine is more likely than venlafaxine to cause suicidal ideation, induce mania, and produce euphoric mood, indicating potential for abuse. Caution is warranted when using esketamine.
Study at a glance
| Key finding | Esketamine is more likely than venlafaxine to cause suicidal ideation, induce mania, and produce euphoric mood, suggesting abuse potential. |
|---|
Abstract
Esketamine appears more likely than venlafaxine to cause suicidal ideation. Induction of mania was more common than with venlafaxine. Induction of euphoric mood suggests abuse potential. Caution is warranted.